Petar Pop-Damkov
AstraZeneca (South Korea)(KR)AstraZeneca (Netherlands)(NL)AstraZeneca (Brazil)(BR)AstraZeneca (United States)(US)
Publications by Year
Research Areas
Immune cells in cancer, Synthesis and Catalytic Reactions, Cancer Research and Treatments, Mast cells and histamine, Cancer-related Molecular Pathways
Most-Cited Works
- → AZD4573 Is a Highly Selective CDK9 Inhibitor That Suppresses MCL-1 and Induces Apoptosis in Hematologic Cancer Cells(2019)289 cited
- → On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology(2020)284 cited
- → Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy(2021)90 cited
- → Development of a quantification method for adenosine in tumors by LC-MS/MS with dansyl chloride derivatization(2018)28 cited
- → Preparation and Characterization of Albumin Conjugates of a Truncated Peptide YY Analogue for Half-Life Extension(2013)28 cited
- → Feasibility of Singlet Analysis for Ligand Binding Assays: a Retrospective Examination of Data Generated Using the Gyrolab Platform(2016)18 cited